PARKINSON DISEASE (Disorder)NCT07555847
Effect of Kinesiotaping on Tremor in People With Parkinson's Disease
A study testing Therapeutic Kinesiotaping and Home Exercise Program in people with PARKINSON DISEASE (Disorder) and Tremor, run by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey at 1 site in Turkey (Türkiye).
Trial summary
The goal of this clinical trial is to learn whether adding kinesiotaping to a strengthening and stretching home-exercise program can reduce hand tremor and improve hand function in people with Parkinson's disease. Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- PARKINSON DISEASE (Disorder), Tremor, Tremor Associated With Tremor Dominant Parkinson's Disease
- What is being tested?
- Therapeutic Kinesiotaping and Home Exercise Program
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 45 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Mar 2025to 1 Jan 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Diagnosis of idiopathic Parkinson's disease
- Hoehn and Yahr stage 1-4
- Presence of hand tremor
- Mini-Mental State Examination (MMSE) score ≥ 23
- Stable medical treatment for at least 3 months prior to enrollment and no planned changes during the study period
- Age between 18 and 80 years
- Ability to understand and provide written informed consent
Who cannot join
- Diagnosis of essential tremor or tremor due to causes other than Parkinson's disease
- Advanced motor impairment (severe bradykinesia or dyskinesia)
- History of allergic reaction to kinesiotaping materials
- Presence of other neurological disorders causing tremor (e.g., ALS, multiple sclerosis, cerebellar disorders)
- Severe psychiatric disorders (e.g., major depression, psychosis, severe anxiety)
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
University of Health Sciences, Sultan 2. Abdulhamid Han Training and Research Hospital
Istanbul, Uskudar, 34668
About this study
Official title: Effect of Kinesiotaping on Hand Tremor in Patients With Parkinson's Disease: A Randomized Controlled Trial
The goal of this clinical trial is to learn whether adding kinesiotaping to a strengthening and stretching home-exercise program can reduce hand tremor and improve hand function in people with Parkinson's disease. The study will also examine how true kinesiotaping compares with sham (placebo) taping and with exercise alone in improving tremor frequency, grip strength, fine motor skills, motor symptoms, daily living activities, and quality of life.
Adults aged 18-80 with Parkinson's disease and hand tremor will be randomly assigned to one of three groups:
Read more
Kinesiotaping + Exercise Group: Participants will receive therapeutic kinesiotaping applied to the forearm extensor muscles and wrist for 4 weeks (twice weekly), in addition to a home program of strengthening and stretching exercises.
Sham Taping + Exercise Group: Participants will receive a placebo taping without tension that does not target specific muscles, along with the same exercise program.
Exercise-Only Group: Participants will complete the same home-exercise program without any taping.
Researchers will compare the three groups to see whether kinesiotaping provides additional benefits beyond exercise and whether it performs better than sham taping. Tremor frequency will be measured using an Apple Watch device, and hand strength, dexterity, motor symptoms, and quality of life will be assessed using validated clinical scales.
Read the detailed description
Resting tremor is one of the main motor symptoms in Parkinson's disease and can significantly limit daily activities, fine motor skills, and upper-extremity function. This clinical trial is designed to evaluate whether adding therapeutic kinesiotaping to a home-based exercise program can reduce hand tremor and improve hand function. The study also aims to compare the effectiveness of true kinesiotaping with sham (placebo) taping and to determine whether either method provides additional benefit beyond exercise alone.
This randomized, controlled, three-arm clinical trial will include participants aged 18 to 80 years who have been diagnosed with Parkinson's disease and experience hand tremor. Participants will be randomly assigned to one of three groups: (1) Kinesiotaping + Exercise, (2) Sham Taping + Exercise, or (3) Exercise Only. All participants will receive a standardized home-exercise program that includes strengthening and stretching exercises targeting forearm muscles. The exercise program will be performed once daily for four weeks.
In the kinesiotaping group, therapeutic taping will be applied to the forearm extensor muscles and wrist using functional taping techniques with appropriate tension and directional application. This approach aims to enhance proprioceptive input, improve muscle activation, and reduce tremor amplitude. In the sham taping group, tape will be applied without therapeutic tension and without following muscle-fiber orientation, providing a placebo intervention. The control group will receive the exercise program only, without any taping.
Tremor severity and frequency will be assessed using accelerometer data from an Apple Watch worn on the affected wrist. Grip strength will be measured with a Jamar dynamometer, and hand dexterity will be evaluated using the Nine Hole Peg Test. Motor symptoms will be assessed with the MDS-UPDRS Part 3, and quality of life will be evaluated using the Parkinson's Disease Questionnaire (PDQ-39). Outcomes will be measured at baseline (T0), at the end of the 4-week intervention (T1), and two weeks after the end of treatment (T2).
The primary objective of this study is to determine whether kinesiotaping provides additional benefit in reducing hand tremor compared with exercise alone. Secondary objectives include evaluating improvements in hand function, changes in grip strength, changes in motor symptoms, and improvements in quality-of-life measures. Kinesiotaping is expected to support tremor control by enhancing proprioceptive feedback. The sham taping group is included to control for placebo effects and to distinguish the specific therapeutic contribution of true kinesiotaping.
This study aims to provide clinical evidence on the usefulness of kinesiotaping as an adjunct to exercise for managing tremor in individuals with Parkinson's disease. The three-arm design will allow clear comparison between true taping, sham taping, and exercise alone, helping to identify the unique effects of kinesiotaping.
- Conditions
- PARKINSON DISEASE (Disorder), Tremor, Tremor Associated With Tremor Dominant Parkinson's Disease
- Being tested
- Therapeutic Kinesiotaping, Sham Taping, Home Exercise Program
- Keywords
- Kinesiotaping, Kinesiologic taping, Parkinson tremor, Hand tremor, Upper extremity tremor, Forearm extensor taping, Sham taping, Exercise therapy, Home exercise program, MDS-UPDRS, PDQ-39, Nine Hole Peg Test, Grip strength, Apple Watch, tremor measurement
- Medical subject headings
- Parkinson Disease, Tremor
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Therapeutic KinesiotapingOther
Kinesiotaping applied to forearm extensor muscles with therapeutic tension and direction, twice weekly for 4 weeks
Sham TapingOther
Placebo taping applied without therapeutic tension and without muscle alignment, twice weekly for 4 weeks
Home Exercise ProgramBehavioural
Daily strengthening and stretching exercises targeting forearm muscles, performed for 4 weeks.
| Study group | Role | What they receive |
|---|---|---|
| Kinesiotaping + Exercise | Experimental | Participants receive therapeutic kinesiotaping applied to the forearm extensor muscles and wrist twice weekly for 4 weeks, in addition to a daily home-based strengthening and stretching exercise program. Receives: Other: Therapeutic Kinesiotaping; Behavioral: Home Exercise Program |
| Sham Taping + Exercise | Sham comparator | Participants receive sham taping without therapeutic tension and without following muscle-fiber orientation, applied twice weekly for 4 weeks, along with the same daily home-based exercise program Receives: Other: Sham Taping; Behavioral: Home Exercise Program |
| Exercise Only | Active comparator | Participants complete the standardized daily home-based strengthening and stretching exercise program for 4 weeks, with no taping applied Receives: Behavioral: Home Exercise Program |
What is being measured
The primary outcome is the main question the study is designed to answer.
Tremor Frequency (Hz)
Change in dominant tremor frequency measured using Apple Watch sensors (accelerometer and gyroscope) during a standardized 60-second recording period. Lower frequency values indicate improvement in tremor severity.
Measured: Baseline (Day 0), End of treatment (Week 4), and Follow-up (Week 8; 4 weeks after treatment completion)
Secondary outcomes (7)
Hand Grip Strength (kg)
Measured using a Jamar hand dynamometer. Higher values indicate better muscle strength.
Measured: Time Frame: Baseline (Day 0), End of treatment (Week 4), and Follow-up (Week 8; 4 weeks after treatment completion)
Pinch Strength (kg)
Measured using a Jamar pinch meter. Higher values indicate better finger strength.
Measured: Time Frame: Baseline (Day 0), End of treatment (Week 4), and Follow-up (Week 8; 4 weeks after treatment completion)
Fahn-Tolosa-Marin Tremor Rating Scale Score
Clinician-rated scale assessing tremor severity. Scores range from 0 to 144, with higher scores indicating more severe tremor.
Measured: Time Frame: Baseline (Day 0), End of treatment (Week 4), and Follow-up (Week 8; 4 weeks after treatment completion)
Nine-Hole Peg Test
Measures fine motor dexterity and hand coordination. Shorter completion time indicates better performance.
Measured: Time Frame: Baseline (Day 0), End of treatment (Week 4), and Follow-up (Week 8; 4 weeks after treatment completion)
MDS-UPDRS Part III Score
Clinician-rated motor examination assessing severity of Parkinsonian motor symptoms. Scores range from 0 to 132, with higher scores indicating worse motor impairment.
Measured: Time Frame: Baseline (Day 0), End of treatment (Week 4), and Follow-up (Week 8; 4 weeks after treatment completion)
Parkinson's Disease Questionnaire-39 (PDQ-39) Score
Patient-reported quality of life measure. Scores range from 0 to 100, with higher scores indicating worse quality of life.
Measured: Time Frame: Baseline (Day 0), End of treatment (Week 4), and Follow-up (Week 8; 4 weeks after treatment completion)
Barthel Index Score
Measures independence in activities of daily living. Scores range from 0 to 100, with higher scores indicating greater independence.
Measured: Time Frame: Baseline (Day 0), End of treatment (Week 4), and Follow-up (Week 8; 4 weeks after treatment completion)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Apr 2026
- Study start1 Mar 2025
- Primary completion1 Nov 2025
- Study completion1 Jan 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (6)Papers the sponsor has linked to this study.
- Other trials for PARKINSON DISEASE (Disorder)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Three-arm parallel design comparing kinesiotaping plus exercise, sham taping plus exercise, and exercise alone in individuals with Parkinson's disease and hand tremor.
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 45 participants (actual)
Sponsor and investigators
- Lead sponsor
- Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mehmet Akif Güler, Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
- Investigators
- Mehmet Akif Guler, Principal investigator, University of Health Sciences, Sultan 2. Abdulhamid Han Training and Research Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07555847
- Sponsor's protocol ID
- PD-KT-RCT-2025
- Status last verified
- Apr 2026
- First submitted
- 14 Apr 2026
- Last updated
- 29 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data (IPD) will not be shared due to patient privacy concerns, institutional policies, and the lack of a predefined data-sharing infrastructure for this single-center academic study.
Publications
Giray E, Karali-Bingul D, Akyuz G. The Effectiveness of Kinesiotaping, Sham Taping or Exercises Only in Lateral Epicondylitis Treatment: A Randomized Controlled Study. PM R. 2019 Jul;11(7):681-693. doi: 10.1002/pmrj.12067. Epub 2019 Mar 28.
PubMed 30609278Dai H, Lin H, Lueth TC. Quantitative assessment of parkinsonian bradykinesia based on an inertial measurement unit. Biomed Eng Online. 2015 Jul 12;14:68. doi: 10.1186/s12938-015-0067-8.
PubMed 26164814Shahien M, Elaraby A, Gamal M, Abdelazim E, Abdelazeem B, Ghaith HS, Negida A. Physical therapy interventions for the management of hand tremors in patients with Parkinson's disease: a systematic review. Neurol Sci. 2023 Feb;44(2):461-470. doi: 10.1007/s10072-022-06420-1. Epub 2022 Oct 7.
PubMed 36205810Mahadevan N, Demanuele C, Zhang H, Volfson D, Ho B, Erb MK, Patel S. Development of digital biomarkers for resting tremor and bradykinesia using a wrist-worn wearable device. NPJ Digit Med. 2020 Jan 15;3:5. doi: 10.1038/s41746-019-0217-7. eCollection 2020.
PubMed 31970290Bravi R, Quarta E, Cohen EJ, Gottard A, Minciacchi D. A little elastic for a better performance: kinesiotaping of the motor effector modulates neural mechanisms for rhythmic movements. Front Syst Neurosci. 2014 Sep 25;8:181. doi: 10.3389/fnsys.2014.00181. eCollection 2014.
PubMed 25309355Capecci M, Serpicelli C, Fiorentini L, Censi G, Ferretti M, Orni C, Renzi R, Provinciali L, Ceravolo MG. Postural rehabilitation and Kinesio taping for axial postural disorders in Parkinson's disease. Arch Phys Med Rehabil. 2014 Jun;95(6):1067-75. doi: 10.1016/j.apmr.2014.01.020. Epub 2014 Feb 5.
PubMed 24508531
Study at a glance
From the registry record, last updated by the sponsor on 29 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Kinesiotaping on Hand Tremor in Patients With Parkinson's Disease: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07555847
- Acronym / sponsor ID
- PD-KT-RCT-2025
- Conditions
- PARKINSON DISEASE (Disorder), Tremor, Tremor Associated With Tremor Dominant Parkinson's Disease
- Keywords
- Kinesiotaping, Kinesiologic taping, Parkinson tremor, Hand tremor, Upper extremity tremor, Forearm extensor taping, Sham taping, Exercise therapy
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 45 participants (actual)
- Lead sponsor
- Sultan Abdulhamid Han Training and Research Hospital, Istanbul, TurkeyUniversity, hospital or other
- Study start
- 1 Mar 2025 (actual)
- Primary completion
- 1 Nov 2025 (actual)
- Study completion
- 1 Jan 2026 (actual)
- First posted
- 29 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to learn whether adding kinesiotaping to a strengthening and stretching home-exercise program can reduce hand tremor and improve hand function in people with Parkinson's disease. The study will also examine how true kinesiotaping compares with sham (placebo) taping and with exercise alone in improving tremor frequency, grip strength, fine motor skills, motor symptoms, daily living activities, and quality of life.
Adults aged 18-80 with Parkinson's disease and hand tremor will be randomly assigned to one of three groups:
Kinesiotaping + Exercise Group: Participants will receive therapeutic kinesiotaping applied to the forearm extensor muscles and wrist for 4 weeks (twice weekly), in addition to a home program of strengthening and stretching exercises.
Sham Taping + Exercise Group: Participants will receive a placebo taping without tension that does not target specific muscles, along with the same exercise program.
Exercise-Only Group: Participants will complete the same home-exercise program without any taping.
Researchers will compare the three groups to see whether kinesiotaping provides additional benefits beyond exercise and whether it performs better than sham taping. Tremor frequency will be measured using an Apple Watch device, and hand strength, dexterity, motor symptoms, and quality of life will be assessed using validated clinical scales.
Detailed description
Resting tremor is one of the main motor symptoms in Parkinson's disease and can significantly limit daily activities, fine motor skills, and upper-extremity function. This clinical trial is designed to evaluate whether adding therapeutic kinesiotaping to a home-based exercise program can reduce hand tremor and improve hand function. The study also aims to compare the effectiveness of true kinesiotaping with sham (placebo) taping and to determine whether either method provides additional benefit beyond exercise alone.
This randomized, controlled, three-arm clinical trial will include participants aged 18 to 80 years who have been diagnosed with Parkinson's disease and experience hand tremor. Participants will be randomly assigned to one of three groups: (1) Kinesiotaping + Exercise, (2) Sham Taping + Exercise, or (3) Exercise Only. All participants will receive a standardized home-exercise program that includes strengthening and stretching exercises targeting forearm muscles. The exercise program will be performed once daily for four weeks.
In the kinesiotaping group, therapeutic taping will be applied to the forearm extensor muscles and wrist using functional taping techniques with appropriate tension and directional application. This approach aims to enhance proprioceptive input, improve muscle activation, and reduce tremor amplitude. In the sham taping group, tape will be applied without therapeutic tension and without following muscle-fiber orientation, providing a placebo intervention. The control group will receive the exercise program only, without any taping.
Tremor severity and frequency will be assessed using accelerometer data from an Apple Watch worn on the affected wrist. Grip strength will be measured with a Jamar dynamometer, and hand dexterity will be evaluated using the Nine Hole Peg Test. Motor symptoms will be assessed with the MDS-UPDRS Part 3, and quality of life will be evaluated using the Parkinson's Disease Questionnaire (PDQ-39). Outcomes will be measured at baseline (T0), at the end of the 4-week intervention (T1), and two weeks after the end of treatment (T2).
The primary objective of this study is to determine whether kinesiotaping provides additional benefit in reducing hand tremor compared with exercise alone. Secondary objectives include evaluating improvements in hand function, changes in grip strength, changes in motor symptoms, and improvements in quality-of-life measures. Kinesiotaping is expected to support tremor control by enhancing proprioceptive feedback. The sham taping group is included to control for placebo effects and to distinguish the specific therapeutic contribution of true kinesiotaping.
This study aims to provide clinical evidence on the usefulness of kinesiotaping as an adjunct to exercise for managing tremor in individuals with Parkinson's disease. The three-arm design will allow clear comparison between true taping, sham taping, and exercise alone, helping to identify the unique effects of kinesiotaping.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 3
- Model description
- Three-arm parallel design comparing kinesiotaping plus exercise, sham taping plus exercise, and exercise alone in individuals with Parkinson's disease and hand tremor.
| Arm | Type | Receives |
|---|---|---|
| Kinesiotaping + Exercise | Experimental | Other: Therapeutic Kinesiotaping, Behavioral: Home Exercise ProgramParticipants receive therapeutic kinesiotaping applied to the forearm extensor muscles and wrist twice weekly for 4 weeks, in addition to a daily home-based strengthening and stretching exercise program. |
| Sham Taping + Exercise | Sham comparator | Other: Sham Taping, Behavioral: Home Exercise ProgramParticipants receive sham taping without therapeutic tension and without following muscle-fiber orientation, applied twice weekly for 4 weeks, along with the same daily home-based exercise program |
| Exercise Only | Active comparator | Behavioral: Home Exercise ProgramParticipants complete the standardized daily home-based strengthening and stretching exercise program for 4 weeks, with no taping applied |
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Diagnosis of idiopathic Parkinson's disease
- Hoehn and Yahr stage 1-4
- Presence of hand tremor
- Mini-Mental State Examination (MMSE) score ≥ 23
- Stable medical treatment for at least 3 months prior to enrollment and no planned changes during the study period
Key exclusion criteria (5 listed)
- Diagnosis of essential tremor or tremor due to causes other than Parkinson's disease
- Advanced motor impairment (severe bradykinesia or dyskinesia)
- History of allergic reaction to kinesiotaping materials
- Presence of other neurological disorders causing tremor (e.g., ALS, multiple sclerosis, cerebellar disorders)
- Severe psychiatric disorders (e.g., major depression, psychosis, severe anxiety)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Therapeutic KinesiotapingKinesiotaping applied to forearm extensor muscles with therapeutic tension and direction, twice weekly for 4 weeks | Other | Kinesiotaping + Exercise |
| Sham TapingPlacebo taping applied without therapeutic tension and without muscle alignment, twice weekly for 4 weeks | Other | Sham Taping + Exercise |
| Home Exercise ProgramDaily strengthening and stretching exercises targeting forearm muscles, performed for 4 weeks. | Behavioural | Exercise Only, Kinesiotaping + Exercise, Sham Taping + Exercise |
Primary outcome
Tremor Frequency (Hz)
Time frame: Baseline (Day 0), End of treatment (Week 4), and Follow-up (Week 8; 4 weeks after treatment completion)
Change in dominant tremor frequency measured using Apple Watch sensors (accelerometer and gyroscope) during a standardized 60-second recording period. Lower frequency values indicate improvement in tremor severity.
7 secondary outcomes
Hand Grip Strength (kg)
Time frame: Time Frame: Baseline (Day 0), End of treatment (Week 4), and Follow-up (Week 8; 4 weeks after treatment completion)
Pinch Strength (kg)
Time frame: Time Frame: Baseline (Day 0), End of treatment (Week 4), and Follow-up (Week 8; 4 weeks after treatment completion)
Fahn-Tolosa-Marin Tremor Rating Scale Score
Time frame: Time Frame: Baseline (Day 0), End of treatment (Week 4), and Follow-up (Week 8; 4 weeks after treatment completion)
Nine-Hole Peg Test
Time frame: Time Frame: Baseline (Day 0), End of treatment (Week 4), and Follow-up (Week 8; 4 weeks after treatment completion)
MDS-UPDRS Part III Score
Time frame: Time Frame: Baseline (Day 0), End of treatment (Week 4), and Follow-up (Week 8; 4 weeks after treatment completion)
Parkinson's Disease Questionnaire-39 (PDQ-39) Score
Time frame: Time Frame: Baseline (Day 0), End of treatment (Week 4), and Follow-up (Week 8; 4 weeks after treatment completion)
Barthel Index Score
Time frame: Time Frame: Baseline (Day 0), End of treatment (Week 4), and Follow-up (Week 8; 4 weeks after treatment completion)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Apr 2026.
- Background: PubMed 30609278Giray E, Karali-Bingul D, Akyuz G. The Effectiveness of Kinesiotaping, Sham Taping or Exercises Only in Lateral Epicondylitis Treatment: A Randomized Controlled Study. PM R. 2019 Jul;11(7):681-693. doi: 10.1002/pmrj.12067. Epub 2019 Mar 28.
- Background: PubMed 26164814Dai H, Lin H, Lueth TC. Quantitative assessment of parkinsonian bradykinesia based on an inertial measurement unit. Biomed Eng Online. 2015 Jul 12;14:68. doi: 10.1186/s12938-015-0067-8.
- Background: PubMed 36205810Shahien M, Elaraby A, Gamal M, Abdelazim E, Abdelazeem B, Ghaith HS, Negida A. Physical therapy interventions for the management of hand tremors in patients with Parkinson's disease: a systematic review. Neurol Sci. 2023 Feb;44(2):461-470. doi: 10.1007/s10072-022-06420-1. Epub 2022 Oct 7.
- Background: PubMed 31970290Mahadevan N, Demanuele C, Zhang H, Volfson D, Ho B, Erb MK, Patel S. Development of digital biomarkers for resting tremor and bradykinesia using a wrist-worn wearable device. NPJ Digit Med. 2020 Jan 15;3:5. doi: 10.1038/s41746-019-0217-7. eCollection 2020.
- Background: PubMed 25309355Bravi R, Quarta E, Cohen EJ, Gottard A, Minciacchi D. A little elastic for a better performance: kinesiotaping of the motor effector modulates neural mechanisms for rhythmic movements. Front Syst Neurosci. 2014 Sep 25;8:181. doi: 10.3389/fnsys.2014.00181. eCollection 2014.
- Background: PubMed 24508531Capecci M, Serpicelli C, Fiorentini L, Censi G, Ferretti M, Orni C, Renzi R, Provinciali L, Ceravolo MG. Postural rehabilitation and Kinesio taping for axial postural disorders in Parkinson's disease. Arch Phys Med Rehabil. 2014 Jun;95(6):1067-75. doi: 10.1016/j.apmr.2014.01.020. Epub 2014 Feb 5.
- Individual participant dataSharing planned: No. Individual participant data (IPD) will not be shared due to patient privacy concerns, institutional policies, and the lack of a predefined data-sharing infrastructure for this single-center academic study.
Related trials for PARKINSON DISEASE (Disorder)
Not yet recruitingPhase 1/2
STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic Carcinoma
NSCLC, Non-Small Cell Lung Cancer
Enrolling by invitationObservational study
Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes
PARKINSON DISEASE (Disorder), Atypical Parkinsonism
RecruitingPhase 3
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Cervical Cancer
Active, not recruitingPhase 1/2
Clinical Safety and Efficacy of Umbilical Cord Mesenchymal Stromal Cells-derived Exosomes in Patients With Parkinson's Disease
Parkinson Disease (PD)
Active, not recruitingObservational study
Adaptive DBS to Offset STN Dysregulation During Exercise in PD
Parkinson Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mehmet Akif Guler principal investigator
University of Health Sciences, Sultan 2. Abdulhamid Han Training and Research Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Therapeutic Kinesiotaping and Home Exercise Program in people with PARKINSON DISEASE (Disorder) and Tremor, run by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 29 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Tremor Frequency (Hz) (time frame: Baseline (Day 0), End of treatment (Week 4), and Follow-up (Week 8; 4 weeks after treatment completion)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07555847, which also lists 6 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Apr 2026.